Difference between revisions of "Part:BBa K1997002"

(Functional Test)
 
(7 intermediate revisions by 2 users not shown)
Line 5: Line 5:
 
This is the N-terminal of split luciferase reporter. It can be used for protein-protein interaction researches.
 
This is the N-terminal of split luciferase reporter. It can be used for protein-protein interaction researches.
  
<!-- Add more about the biology of this part here
 
 
===Usage and Biology===
 
===Usage and Biology===
  
 +
Luciferase is a generic term for the class of oxidative enzymes that produce bioluminescence, and is distinct from a photoprotein. The name is derived from Lucifer, the root of which means 'light-bearer' (lucem ferre).
 +
 +
The protein structure of firefly luciferase consists of two compact domains: the N-terminal domain and the C-terminal domain. The N-terminal domain is composed of two β-sheets in an αβαβα structure and a β barrel. The two β-sheets stack on top of each other, with the β-barrel covering the end of the sheets.<sup>1 </sup>. 
 +
 +
The C-terminal domain is connected to the N-terminal domain by a flexible hinge, which can separate the two domains. The amino acid sequences on the surface of the two domains facing each other are conserved in bacterial and firefly luciferase, thereby strongly suggesting that the active site is located in the cleft between the domains. <sup>2 </sup>.
 +
 +
Luciferase is a heat-sensitive protein that is used in studies on protein denaturation, testing the protective capacities of heat shock proteins. The opportunities for using luciferase continue to expand.
 +
 +
 +
===Sequence and Features===
 
<!-- -->
 
<!-- -->
 
<span class='h3bb'>Sequence and Features</span>
 
<span class='h3bb'>Sequence and Features</span>
 
<partinfo>BBa_K1997002 SequenceAndFeatures</partinfo>
 
<partinfo>BBa_K1997002 SequenceAndFeatures</partinfo>
  
 +
==Experimental Validation==
  
<!-- Uncomment this to enable Functional Parameter display
+
This part is validated through four ways: enzyme cutting, PCR, Sequence, and functional testing
===Functional Parameters===
+
 
<partinfo>BBa_K1997002 parameters</partinfo>
+
===Sequencing===
<!-- -->
+
 
 +
This part is sequenced as correct after construction.
 +
 
 +
===PCR===
 +
 
 +
'''Methods'''
 +
 
 +
The PCR is performed with Premix EX Taq by Takara.
 +
 
 +
F-Prime: 5’- GAATTCGCGGCCGCTTCTAGAATGC-3’
 +
 
 +
R-Prime: 5’- GGACTAGTATTATTGTTTGTCTGCC-3’
 +
 
 +
The PCR protocol is selected based on the Users Manuel.
 +
The Electrophoresis was performed on a 1% Agarose glu.
 +
The result of the agarose electrophoresis was shown on the picture below.
 +
 
 +
[[File:NUDT-002-1.jpg|300px|]]
 +
 
 +
===Enzyme digestion test ===
 +
 
 +
'''Methods'''
 +
 
 +
After the assembly ,the plasmid was transferred into the Competent ''E. coli'' DH5α). After culturing overnight in LB,we minipreped the plasmid for cutting.
 +
The preparation of the plasmid was performed with TIANprep Mini Plasmid Kit from ''TIANGEN''. The cutting procedure was performed with EcoRI and SpeI restriction endonuclease bought from ''TAKARA''.
 +
 
 +
The plasmid was cutted in a 20μL system at 37 ℃ for 2 hours.
 +
The Electrophoresis was performed on a 1% Agarose glu.
 +
 
 +
The result of the agarose electrophoresis was shown on the picture above.
 +
 
 +
===Functional Test===
 +
This part is tested together with the part BBa_K1997003, in the composite part BBa_K19970021 and BBa_K19970022.
 +
 
 +
To proof the basic function of our split-luciferase  reporting system, two devices, containing split-LUC fragments and a complete (or split as control) zinc finger protein, were built under control of a lac operon controlled T7 promoter. The complete zinc finger protein was to stimulate a PPI positive situation, while the split one was to stimulate a PPI negative situation.
 +
 
 +
For such assay, E.coli carrying respective plasmid was cultured overnight under IPTG induction. Cells were then collected and lysed by high-pressure homogenizer. Once lysed and ultra-filtrated (to remove small molecules), with D-luciferin substrate solution was added into the cell lysate for the measurement of luciferase activity.
 +
 
 +
Chemo-luminescence assay showed significant variation between the PPI positive group and the PPI negative group. Thus then validated the function of this part.
 +
 
 +
[[File:T--NUDT_CHINA--partsfig8.jpg|700px|]]
 +
 
 +
 
 +
Figure 1. Evaluation of the Signal-Noise Ratio of split LUC system (A) Schematic representation of the evaluation protocol. The complete Zif-268 protein was introduced to simulate the condition where strong interaction among two proteins occur, whereas the split-zif protein was used to simulate the condition where no interaction exists.(B) Experimment showing the RLU under two different conditions. Relative RLU was calculated with normalization of RLU. This experiment was run in three parallel reactions, and the data represent results obtained from at least three independent experiments. **p<0.01.
 +
 
 +
===References===
  
 +
[1]Gould SJ, Subramani S (Nov 1988). "Firefly luciferase as a tool in molecular and cell biology". Analytical Biochemistry. 175(1): 5–13. doi:10.1016/0003-2697(88)90353-3. PMID 3072883.
  
[[File:NUDT-000-1.jpeg|150px|]]
+
[2]Steghens JP, Min KL, Bernengo JC (Nov 1998). "Firefly luciferase has two nucleotide binding sites: effect of nucleoside monophosphate and CoA on the light-emission spectra". The Biochemical Journal. 336 ( Pt 1) (1): 109–13. PMC 1219848 . PMID 9806891.

Latest revision as of 01:04, 21 October 2016


sLuc-N

This is the N-terminal of split luciferase reporter. It can be used for protein-protein interaction researches.

Usage and Biology

Luciferase is a generic term for the class of oxidative enzymes that produce bioluminescence, and is distinct from a photoprotein. The name is derived from Lucifer, the root of which means 'light-bearer' (lucem ferre).

The protein structure of firefly luciferase consists of two compact domains: the N-terminal domain and the C-terminal domain. The N-terminal domain is composed of two β-sheets in an αβαβα structure and a β barrel. The two β-sheets stack on top of each other, with the β-barrel covering the end of the sheets.1 .

The C-terminal domain is connected to the N-terminal domain by a flexible hinge, which can separate the two domains. The amino acid sequences on the surface of the two domains facing each other are conserved in bacterial and firefly luciferase, thereby strongly suggesting that the active site is located in the cleft between the domains. 2 .

Luciferase is a heat-sensitive protein that is used in studies on protein denaturation, testing the protective capacities of heat shock proteins. The opportunities for using luciferase continue to expand.


Sequence and Features

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal BamHI site found at 1300
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]

Experimental Validation

This part is validated through four ways: enzyme cutting, PCR, Sequence, and functional testing

Sequencing

This part is sequenced as correct after construction.

PCR

Methods

The PCR is performed with Premix EX Taq by Takara.

F-Prime: 5’- GAATTCGCGGCCGCTTCTAGAATGC-3’

R-Prime: 5’- GGACTAGTATTATTGTTTGTCTGCC-3’

The PCR protocol is selected based on the Users Manuel. The Electrophoresis was performed on a 1% Agarose glu. The result of the agarose electrophoresis was shown on the picture below.

NUDT-002-1.jpg

Enzyme digestion test

Methods

After the assembly ,the plasmid was transferred into the Competent E. coli DH5α). After culturing overnight in LB,we minipreped the plasmid for cutting. The preparation of the plasmid was performed with TIANprep Mini Plasmid Kit from TIANGEN. The cutting procedure was performed with EcoRI and SpeI restriction endonuclease bought from TAKARA.

The plasmid was cutted in a 20μL system at 37 ℃ for 2 hours. The Electrophoresis was performed on a 1% Agarose glu.

The result of the agarose electrophoresis was shown on the picture above.

Functional Test

This part is tested together with the part BBa_K1997003, in the composite part BBa_K19970021 and BBa_K19970022.

To proof the basic function of our split-luciferase reporting system, two devices, containing split-LUC fragments and a complete (or split as control) zinc finger protein, were built under control of a lac operon controlled T7 promoter. The complete zinc finger protein was to stimulate a PPI positive situation, while the split one was to stimulate a PPI negative situation.

For such assay, E.coli carrying respective plasmid was cultured overnight under IPTG induction. Cells were then collected and lysed by high-pressure homogenizer. Once lysed and ultra-filtrated (to remove small molecules), with D-luciferin substrate solution was added into the cell lysate for the measurement of luciferase activity.

Chemo-luminescence assay showed significant variation between the PPI positive group and the PPI negative group. Thus then validated the function of this part.

T--NUDT CHINA--partsfig8.jpg


Figure 1. Evaluation of the Signal-Noise Ratio of split LUC system (A) Schematic representation of the evaluation protocol. The complete Zif-268 protein was introduced to simulate the condition where strong interaction among two proteins occur, whereas the split-zif protein was used to simulate the condition where no interaction exists.(B) Experimment showing the RLU under two different conditions. Relative RLU was calculated with normalization of RLU. This experiment was run in three parallel reactions, and the data represent results obtained from at least three independent experiments. **p<0.01.

References

[1]Gould SJ, Subramani S (Nov 1988). "Firefly luciferase as a tool in molecular and cell biology". Analytical Biochemistry. 175(1): 5–13. doi:10.1016/0003-2697(88)90353-3. PMID 3072883.

[2]Steghens JP, Min KL, Bernengo JC (Nov 1998). "Firefly luciferase has two nucleotide binding sites: effect of nucleoside monophosphate and CoA on the light-emission spectra". The Biochemical Journal. 336 ( Pt 1) (1): 109–13. PMC 1219848 . PMID 9806891.